Animal Health Inc Elanco serves as Executive at Kindred Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Animal Health Inc Elanco has executed 1 insider transactions totaling $421.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 27, 2021 involved purchasing 45,508,938 shares valued at $421.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 27, 2021 | KIN | $421.0M | Purchase | 45,508,938 | $9.25 | Discretionary |
Animal Health Inc Elanco currently holds 10,000 shares of Kindred Biosciences, Inc. (KIN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Animal Health Inc Elanco has been a net buyer of KIN stock. They have purchased $421.0M and sold $0 worth of shares.
Animal Health Inc Elanco's most recent insider trade was on Aug 27, 2021, when they purchased 45,508,938 shares at $9.25 per share.
Get notified when new Form 4 filings are submitted